Results
176
Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.
176 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CWBC | US$15.48 | 2.2% | 22.3% | US$137.0m | US$18.00 | PB1.2x | n/a | 2.1% | Banks | ||
GABC | US$40.22 | -2.2% | 25.1% | US$1.2b | US$48.67 | PB1.6x | E22.3% | 2.7% | Banks | ||
RGCO New | US$20.06 | -1.3% | 5.3% | US$205.9m | US$27.00 | PE17.5x | S5.2% | 4.1% | Utilities | ||
FUNC | US$33.71 | -0.9% | 42.2% | US$218.1m | n/a | PB1.3x | E15.1% | 2.6% | Banks | ||
FRAF | US$29.90 | -1.8% | 4.8% | US$132.0m | n/a | PB0.9x | n/a | 4.3% | Banks | ||
NXR.UN | CA$7.69 | 0.5% | -7.5% | CA$724.1m | CA$9.00 | PB0.5x | E12.0% | 8.3% | Real Estate | ||
PLOW New | US$23.63 | -0.1% | -13.1% | US$545.7m | US$32.33 | PE10.1x | E-3.7% | 5.0% | Capital Goods | ||
CFW | CA$3.79 | 0.5% | -16.0% | CA$325.4m | CA$5.17 | PE11.6x | E29.8% | 0% | Energy | ||
PUMP | US$9.33 | 3.3% | 15.9% | US$960.3m | US$10.69 | PS0.7x | E91.7% | n/a | Energy | ||
SABR | US$3.65 | -2.1% | -14.5% | US$1.4b | US$4.54 | PS0.5x | E71.4% | 0% | Consumer Services | ||
NX | US$24.24 | -4.0% | -21.0% | US$1.1b | US$36.33 | PE34.5x | E49.3% | 1.3% | Capital Goods | ||
TLRY | US$1.33 | -10.1% | -41.9% | US$1.2b | US$2.18 | PS1.5x | E71.6% | n/a | Pharmaceuticals & Biotech | ||
DK | US$18.50 | 7.8% | -29.2% | US$1.2b | US$20.14 | PS0.08x | E29.4% | 5.5% | Energy | ||
SIS New | CA$19.89 | -2.1% | 33.9% | CA$1.4b | CA$26.64 | PE30.9x | E31.4% | 2.7% | Capital Goods | ||
PMZ.UN | CA$15.47 | -0.3% | 11.5% | CA$1.5b | CA$18.44 | PB0.7x | E22.2% | 5.4% | Real Estate | ||
HME | CA$1.83 | 0% | 45.2% | CA$178.5m | CA$2.60 | PE6x | E-11.2% | 8.7% | Energy | ||
MI.UN | CA$13.34 | 0.8% | -16.1% | CA$1.2b | CA$18.83 | PB0.8x | S4.6% | 3.9% | Real Estate | ||
CDXC New | US$5.31 | -5.4% | 258.4% | US$406.1m | US$7.96 | PE273.5x | E81.8% | n/a | Pharmaceuticals & Biotech | ||
LMB New | US$85.54 | -3.2% | 99.6% | US$964.3m | US$107.00 | PE36.7x | E19.1% | n/a | Capital Goods | ||
MUX | US$7.78 | -3.4% | 13.1% | US$411.8m | US$14.63 | PE4x | E-106.9% | 0% | Materials | ||
DDR | AU$8.52 | 1.2% | -28.0% | AU$1.5b | AU$10.60 | PE19.2x | E9.4% | 5.3% | Tech | ||
CTD | AU$13.27 | 0.5% | -30.6% | AU$1.9b | AU$13.87 | PE22.3x | E12.1% | 2.2% | Consumer Services | ||
HLS | AU$1.40 | -1.4% | -7.6% | AU$994.8m | AU$1.43 | PS0.6x | E90.1% | 0% | Healthcare | ||
DMMX | Rp242.00 | 4.3% | -18.2% | Rp1.8t | n/a | PS1.3x | n/a | n/a | Media |